Rubicon Research Quarterly Results for Trading Insights
RUBICON • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹54 Cr
QSept 2025
Rubicon Research Quarterly Results Key Highlights
- Revenue of ₹413 Cr in Sept 2025 (+17.0% vs Jun 2025, +38.1% vs Sept 2024)
- Net Profit of ₹54 Cr in Sept 2025 (+25.6% vs Jun 2025, +54.3% vs Sept 2024)
- EBITDA of ₹95 Cr in Sept 2025 (+18.8% vs Jun 2025)
- Operating Margin of 23.0% in Sept 2025 (+1.0pp vs Jun 2025)
- Earnings Per Share of ₹3.49 in Sept 2025 (+24.2% vs Jun 2025)
Rubicon Research Quarterly Results Analysis
| Metric | Sept 2025 | Jun 2025 | Sept 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 413 | 353 | 299 | 317 | 17.0% | 38.1% |
| Net Profit (₹ Cr) | 54 | 43 | 35 | 26 | - | - |
| EBITDA (₹ Cr) | 95 | 80 | 64 | 61 | - | - |
| EPS (₹) | 3.49 | 2.81 | 2.27 | 1.66 | - | - |
| Operating Margin (%) | 23.0% | 22.0% | 21.0% | 19.0% | - | - |
Rubicon Research Share Price Trend Around Quarterly Results
Visualize Rubicon Research's 1-year price movement across quarterly results — ideal for logging trades in Rubicon Research share price
chart using Tickjournal. All values in ₹.
Related Pages for Rubicon Research
Additional stock information and data for RUBICON
Revenue Trend (₹ Cr)
Jun 2024
317
Sept 2024
299
Jun 2025
353
Sept 2025
413
Net Profit Trend (₹ Cr)
Jun 2024
26
Sept 2024
35
Jun 2025
43
Sept 2025
54
Operating Margin Trend (%)
Jun 2024
19.0%
Sept 2024
21.0%
Jun 2025
22.0%
Sept 2025
23.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Rubicon Research quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores